If so, you may have a possible legal case against the manufacturer of the potentially dangerous drug or medical product. Simply fill out the short form below and an experienced legal expert will contact you as soon as possible!

First Name:

Last Name:

Street Address:

City:

State:

Zip:

Daytime Phone Number:

Alternate Phone Number (Optional):

E-Mail Address:

Is this request for you or someone else?
Myself
My Spouse or
Minor Child
Other Relative or Friend

Drug Or Device Exposed To:

Dates Taken:

Related Health Problems Caused By The Drug:

By Clicking Above You Are Agreeing To Our Privacy Policy

Editorial States That Vioxx Could Have Been Valuable If FDA Had Slowed Approval

Added December 30th, 2005

An editorial in the Boston Globe states that had the Food and Drugs Administration been slower in granting approval to the controversial drug Vioxx, manufactured by Merck, the drug could have been serving a genuine purpose and doing some real good by this time rather than being at the center of controversy having been withdrawn from the market due to potentially deadly side effects.

The editorial stated that Vioxx "might be doing some good in limited use today, if only the FDA had slowed the approval process enough for the data about danger to catch up with the marketing hype." The editorial went on to add that "the industry and Congress want these drugs made available quickly, and the drug manufacturers pay the cost of the FDA approval process to hurry them along. This represents a change in attitude from a generation ago, when the FDA was proud of its deliberate pace."

In addition to this, the editorial stated that there were instances where such speed could be warranted such as in medications to treat life threatening diseases, but it also said: "No one wants to return to the days when FDA sluggishness delayed the approval of life-sustaining medicine, but there has to be a middle way between long delays and an approval process that makes millions of pain sufferers into unknowing guinea pigs. Tighter regulations may lessen company profits, but they will ensure that the medicines Americans take are once again considered the safest on Earth."

Editorial States That... | Printable Version (Opens In New Window)

Important Notice: RYAR.org is a legal informational site.The content contained herein was not prepared by lawyers and should not be taken as a substitute for legal advice from a licensed attorney. Additionally, this information is not intended to create an attorney-client relationship simply by its viewing. The creation of an attorney-client relationship requires more than viewing this or affiliated websites. Neither the transmission nor receipt of this website material will create an attorney-client relationship between sender and receiver. The material contained herein is general in nature and may or may not be applicable to a viewer’s individual legal needs. Online readers should not act on this information without seeking professional counsel. Please read our 'Terms & Conditions Of Use' for more information.

Additionally, the information contained on RYAR.org, including but not limited to informational articles, other text/images, and on or off site links, has not been prepared, endorsed, or reviewed by any form of licensed medical professional, including but not limited to physicians, doctors, and so on. Nothing on the this website should be taken as medical advice, but instead should act as a useful resource in providing general information that may be useful to members of the general public. All visitors are encouraged to consult with a physician or other licensed medical professional for any form of medical advice. Please see our 'Terms & Conditions Of Use' for further information